01—Abstract
Summary
Summary of the 8-K filed February 4, 2026. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. (CME) filed an 8-K report on February 4, 2026, announcing its financial results for the fourth quarter and full year ended December 31, 2025.
The report primarily references an attached press release (Exhibit 99.1) which contains detailed financial information and commentary from the company. Investors should note that the press release includes both GAAP and non-GAAP financial measures. The non-GAAP measures, which include revenues, expenses, operating income, net income, and earnings per share, are presented to offer supplemental insights into financial and business trends and to enhance comparability with prior periods.
CME Group emphasizes that these non-GAAP metrics are intended to be used in conjunction with, and not as a substitute for, GAAP-based financial reporting, and a reconciliation between the two is provided in the press release. While the 8-K itself does not contain the specific financial figures, the incorporated press release is the primary source for understanding CME Group's performance.
Investors are encouraged to review Exhibit 99.1 for detailed operational and financial outcomes, including the company's commentary on its performance drivers and outlook. The filing also includes the standard cover page in Inline XBRL format.
02—Key points
Key Highlights
- CME Group Inc. (CME) reported financial results for the quarter and year ended December 31, 2025, via an 8-K filing on February 4, 2026.
- The key financial details are contained within an attached press release (Exhibit 99.1) dated February 4, 2026.
- The press release presents financial results using both Generally Accepted Accounting Principles (GAAP) and non-GAAP measures.
- Non-GAAP financial measures include revenues, expenses, operating income, net income, and earnings per share.
- Management believes non-GAAP measures provide valuable supplemental information for understanding financial trends and comparability.
- A reconciliation of non-GAAP measures to their most directly comparable GAAP measures is included in the press release.
- The filing also includes the Inline XBRL formatted cover page of the report.
03—Questions
Frequently Asked Questions
Where can I find the specific financial results for CME Group for the period ended December 31, 2025?
The detailed financial results are provided in the press release, attached as Exhibit 99.1 to the 8-K filing filed on February 4, 2026. Investors should refer to this exhibit for the specific figures and management's commentary.
What is the significance of the non-GAAP financial measures mentioned in the filing?
The non-GAAP financial measures (revenues, expenses, operating income, net income, and earnings per share) are provided as supplemental information. CME Group's management believes they offer a better view of financial and business trends and enhance comparability with prior periods, but they should not be considered a substitute for GAAP-based results.
Is there a reconciliation between the GAAP and non-GAAP financial figures?
Yes, the press release that is incorporated by reference into this 8-K filing includes a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures, as required by Regulation G.
Does this 8-K filing contain any new forward-looking statements or guidance from CME Group?
This 8-K filing primarily serves to announce financial results for the past period and incorporates a press release. Any forward-looking statements or guidance would be found within that press release (Exhibit 99.1) and should be reviewed carefully, along with any associated disclaimers and risk factors.
04—Continue